Publication | Closed Access
1369 TELAPREVIR SUBSTANTIALLY IMPROVED SVR RATES ACROSS ALL IL28B GENOTYPES IN THE ADVANCE TRIAL
116
Citations
0
References
2011
Year
Clinical ImmunologyImmunodeficienciesImmunologyAntiviral TherapyAntiviral ResponseImmunotherapyMedicine
No additional data available for this publication yet. Check back later!